SLC2A5 and neoplasm: GLUT5 is highly expressed in breast cancer cells19,50 and GLUT5 inhibitors have been developed, such as N-[4-(methanesulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine (MSNBA) (Supplementary Fig. 3a)39,51.